Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)

NCT01106287 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: MK-0941
DRUG: Comparator: Placebo

Sponsor

Merck Sharp & Dohme LLC